PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Immunisation and Countermeasures Division, Public Health England, London, United Kingdom.\', \'Respiratory and Vaccine Preventable Bacterial Reference Unit (RVBRU), Public Health England, London, United Kingdom.\', \'Statistics, Modelling, and Economics Department, Public Health England, London, United Kingdom.\', \'London School of Hygiene and Tropical Medicine, London, United Kingdom.\', \'Paediatric Infectious Diseases Research Group (PIDRG), St George\'s University of London, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/cid/ciaa1728
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33196783
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all